Berkower I - Search Results

1

CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1.

Berkower I, Mostowski H, Bull TE, Murphy D. Berkower I, et al. J Infect Dis. 1996 Apr;173(4):863-9. doi: 10.1093/infdis/173.4.863. J Infect Dis. 1996. PMID: 8603964

2

A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120.

Berkower I, Murphy D, Smith CC, Smith GE. Berkower I, et al. J Virol. 1991 Nov;65(11):5983-90. doi: 10.1128/JVI.65.11.5983-5990.1991. J Virol. 1991. PMID: 1717712 Free PMC article.

3

Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation.

Berkower I, Smith GE, Giri C, Murphy D. Berkower I, et al. J Exp Med. 1989 Nov 1;170(5):1681-95. doi: 10.1084/jem.170.5.1681. J Exp Med. 1989. PMID: 2478654 Free PMC article.

4

Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.

Berkower I, Murphy D. Berkower I, et al. Biochem Biophys Res Commun. 1993 Mar 31;191(3):1055-65. doi: 10.1006/bbrc.1993.1324. Biochem Biophys Res Commun. 1993. PMID: 8466484

5

Anti-Leu3a induces combining site-related anti-idiotypic antibody without inducing anti-HIV activity.

Reeves JP, Buck D, Berkower I, Murphy D, Epstein SL. Reeves JP, et al. Among authors: berkower i. AIDS Res Hum Retroviruses. 1991 Jan;7(1):55-63. doi: 10.1089/aid.1991.7.55. AIDS Res Hum Retroviruses. 1991. PMID: 2015115

6

Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.

He Y, Manischewitz J, Meseda CA, Merchlinsky M, Vassell RA, Sirota L, Berkower I, Golding H, Weiss CD. He Y, et al. Among authors: berkower i. J Infect Dis. 2007 Oct 1;196(7):1026-32. doi: 10.1086/520936. Epub 2007 Aug 20. J Infect Dis. 2007. PMID: 17763325

7

Genetic control of the immune response to HIV type 1 envelope glycoprotein 120 in mice: effects of MHC and transgenic human CD4.

Berkower I, Bridgewater J. Berkower I, et al. AIDS Res Hum Retroviruses. 1998 Jul 1;14(10):893-900. doi: 10.1089/aid.1998.14.893. AIDS Res Hum Retroviruses. 1998. PMID: 9671218

8

Formation of HIV-1 envelope-hepatitis B core antigen hybrids with high affinity for CD4.

Patterson LJ, Aberdeen A, Kone J, Haben M, Raymond M, Berkower I. Patterson LJ, et al. Among authors: berkower i. Biochem Biophys Res Commun. 2001 Jul 20;285(3):639-43. doi: 10.1006/bbrc.2001.5227. Biochem Biophys Res Commun. 2001. PMID: 11453640

9

Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding.

Berkower I, Patel C, Ni Y, Virnik K, Xiang Z, Spadaccini A. Berkower I, et al. Virology. 2008 Aug 1;377(2):330-8. doi: 10.1016/j.virol.2008.03.040. Epub 2008 Jun 2. Virology. 2008. PMID: 18519142 Free article.

10

Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120.

Berkower I, Raymond M, Muller J, Spadaccini A, Aberdeen A. Berkower I, et al. Virology. 2004 Mar 30;321(1):75-86. doi: 10.1016/j.virol.2003.12.017. Virology. 2004. PMID: 15033567 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters